HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diuretics enhance effects of increased dose of candesartan on ambulatory blood pressure reduction in Japanese patients with uncontrolled hypertension treated with medium-dose angiotensin II receptor blockers.

Abstract
Abstract Although blockade of the renin-angiotensin system by increasing the dose of angiotensin II receptor blockers (ARBs) is recommended to achieve clinical benefits in terms of blood pressure (BP) control and cardiovascular and renal outcomes, the effect of this increased dose on ambulatory BP monitoring has not been evaluated completely in Japanese patients with uncontrolled hypertension undergoing medium-dose ARB therapy. The primary objective of this study was to examine the effect of the relatively high dose of the ARB candesartan (12 mg/day) on 24-h systolic BP and the attainment of target BP levels in uncontrolled hypertension treated with a medium dose of ARBs. A total of 146 hypertensive patients (age: 69.9 ± 9.3 years; females: 65.8%) completed the study. After switching to candesartan at 12 mg/day, all these BP measurements decreased significantly (p<0.001). Attainment of the target office BP (p=0.0014) and 24-h BP levels (p=0.0296) also improved significantly. Subgroup analysis indicated that the reduction of 24-h systolic BP was larger in patients treated with diuretics than those without (p=0.0206). Multivariate analysis revealed a significant correlation between the combined ARB and diuretic therapy, and the change in 24-h systolic BP irrespective of preceding ARBs. In conclusion, the switching therapy to increased dose of candesartan caused significant reductions in office and ambulatory BP levels, and improved the attainment of target BP levels in patients with uncontrolled hypertension treated with a medium dose of ARBs. Combination with diuretics enhanced this effect.
AuthorsAtsushi Sakima, Toshihiro Kita, Seigo Nakada, Naoto Yokota, Noboru Tamaki, Takuma Etoh, Toru Shimokubo, Kazuo Kitamura, Shuichi Takishita, Yusuke Ohya
JournalClinical and experimental hypertension (New York, N.Y. : 1993) (Clin Exp Hypertens) Vol. 36 Issue 1 Pg. 40-5 ( 2014) ISSN: 1525-6006 [Electronic] England
PMID23713902 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Observational Study)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Diuretics
  • Tetrazoles
  • candesartan
Topics
  • Aged
  • Angiotensin II Type 1 Receptor Blockers (administration & dosage)
  • Antihypertensive Agents (administration & dosage)
  • Asian People
  • Benzimidazoles (administration & dosage)
  • Biphenyl Compounds
  • Blood Pressure (drug effects)
  • Blood Pressure Monitoring, Ambulatory
  • Diuretics (administration & dosage)
  • Drug Synergism
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Japan
  • Male
  • Middle Aged
  • Renin-Angiotensin System (drug effects)
  • Tetrazoles (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: